Latest News.

ShanX Medtech receives support by the Leadership4SMEs

ShanX Medtech has become part of the Leadership4SMEs community, a community to accelerate IP-driven businesses. This community brings together more than 500 high potential European SMEs and start-ups. From the overall community, 15 start-ups and 15 SMEs with the potential to become success stories have been selected through 2...

ShanX Medtech at ECCMID 2022, Portugal

ShanX Medtech is joining the 32nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Lisbon, Portugal from April 23-26. Contact us at info@shanxmedtech.nl for a face-to-face introduction.  

ShanX Medtech at the Health Valley, NL

Come meet us in Nijmegen! This year, we will be joining the Health Valley Event 2022 on March the 15th to the 17th in Nijmegen, The Netherlands. Not far from home, we are excited to join the conference with the DIGI B CUBE support, where we will showcase our...

ShanX Medtech at the SLAS2022 in Boston, USA

The Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition brings innovators for valuable networking, education and discovery. ShanX Medtech will attend the conference in Boston, MA in the US. The conference will be held from February 5th to February 9th, 2022. Contact us at info@shanxmedtech.nl for a...

ShanX Medtech and Omnigen BV awarded the MIT R&D grant

ShanX Medtech together with Omnigen BV are going to develop a fast diagnostic tool for testing of Urinary Tract Infections under the recently awarded MIT Zuid R&D grant by Stimulus Programmamanagemnt! The two parties bring complementary skills for the implementation of such an innovative project! This innovation is among the...

ShanX Medtech at the Hello Tomorrow Global Summit in Paris

Earlier this year we were recognized as Deep Tech Pioneers by Hello Tomorrow. This allows us to attend the Hello Tomorrow Investor Day and Global Summit in Paris on Dec. 1st - 3rd. The Global Summit welcomes prestigious scientists, entrepreneurs and brilliant minds to discuss, debate and share cutting-edge...

ShanX Medtech at the MEDICA fair in Düsseldorf

MEDICA is taking place in Düsseldorf on November 15-18, 2021. The event is a leading international trade fair, and it is a wonderful place to meet partners in exhibition halls. As such we will be attending the event. If you want to meet us and discover what we do...

ShanX Medtech recognized as a Deep Tech Pioneer by Hello Tomorrow

We are delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that we’ve been recognised by Hello Tomorrow as one the most promising technologies in deep tech to date. Over 4000 technologies were submitted from 115 countries, and ours was...

Founder and CEO, Sophia E. Shanko on the TOPX Summit on 22-23 September

Women are still underrepresented in high level positions even nowadays. Though there are more women than men in Europe only 16% of European startups are founded or co-founded by women. The TOPX Network aims to create a unique and valuable network for ambitious women in Life Sciences by supporting their...

ShanX Medtech is awarded the MIT feasibility study

ShanX Medtech is awarded the MIT- Zuid Feasibility Study Subsidy for Growth, Sustainability and Innovative Economy. This project focuses on the investigation and analysis of the potential of a novel medical technological platform applied for testing of antimicrobial resistance, with the aim of supporting decision making by objectively and rationally...

ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can determine fast antibiotic efficacy.

ShanX Medtech and New Circle Technologies are partnering to develop a prototype software algorithm that can quickly determine antibiotic efficacy. The DIGI-B-CUBE project has been awarded to accelerate the goal of personalized medicine that can eventually offer patients with fast and efficient treatment system.   This project has received funding from...

ShanX Medtech is awarded a grant by the Metropoolregio Eindhoven

Antibiotic resistance is a public global health issue. Unnecessary and injudicious antibiotic use may contribute to the rise of antibiotic resistance. To tackle this use, regulating antibiotic administration is very important. The Metropool Regio Eindhoven is supporting ShanX Medtech in the development of an antibiotic efficiency testing device.

Shanx_medtech_favicon_v1.0

Get in Touch

We’re ready to answer any and all questions!